Annual Shareholders Equity
$2.22 M
-$5.57 M-71.54%
December 31, 2023
Summary
- As of February 7, 2025, EPRX annual stockholders equity is $2.22 million, with the most recent change of -$5.57 million (-71.54%) on December 31, 2023.
- During the last 3 years, EPRX annual shareholders equity has risen by +$18.85 million (+113.32%).
- EPRX annual shareholders equity is now -86.14% below its all-time high of $15.99 million, reached on December 1, 2021.
Performance
EPRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$9.52 M
-$5.31 M-35.81%
September 1, 2024
Summary
- As of February 7, 2025, EPRX quarterly stockholders equity is $9.52 million, with the most recent change of -$5.31 million (-35.81%) on September 1, 2024.
- Over the past year, EPRX quarterly shareholders equity has dropped by -$5.31 million (-35.81%).
- EPRX quarterly shareholders equity is now -58.07% below its all-time high of $22.71 million, reached on June 1, 2021.
Performance
EPRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
EPRX Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -71.5% | -35.8% |
3 y3 years | +113.3% | -40.5% |
5 y5 years | +127.3% | - |
EPRX Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -86.1% | at low | -51.3% | +329.6% |
5 y | 5-year | -86.1% | +113.3% | -58.1% | +157.2% |
alltime | all time | -86.1% | +113.3% | -58.1% | +157.2% |
Eupraxia Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $9.52 M(-35.8%) |
Jun 2024 | - | $14.83 M(-24.1%) |
Mar 2024 | - | $19.54 M(+781.9%) |
Dec 2023 | $2.22 M(-71.5%) | $2.22 M(-82.3%) |
Sep 2023 | - | $12.54 M(+123.4%) |
Jun 2023 | - | $5.61 M(-27.9%) |
Dec 2022 | $7.79 M | - |
Dec 2022 | - | $7.79 M(-47.6%) |
Sep 2022 | - | $14.85 M(-22.5%) |
Jun 2022 | - | $19.17 M(+39.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $13.79 M(-13.7%) |
Dec 2021 | $15.99 M(-196.1%) | $15.99 M(-13.6%) |
Sep 2021 | - | $18.51 M(-18.5%) |
Jun 2021 | - | $22.71 M(+13.9%) |
Mar 2021 | - | $19.94 M(-219.9%) |
Dec 2020 | -$16.63 M(+22.8%) | -$16.63 M(+4.1%) |
Sep 2020 | - | -$15.97 M(+17.9%) |
Dec 2019 | -$13.54 M(+66.8%) | -$13.54 M |
Dec 2018 | -$8.12 M(-270.8%) | - |
Dec 2017 | $4.75 M | - |
FAQ
- What is Eupraxia Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual shareholders equity year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Eupraxia Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of EPRX is $2.22 M
What is the all time high annual shareholders equity for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual stockholders equity is $15.99 M
What is Eupraxia Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, EPRX annual stockholders equity has changed by -$5.57 M (-71.54%)
What is Eupraxia Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of EPRX is $9.52 M
What is the all time high quarterly shareholders equity for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly stockholders equity is $22.71 M
What is Eupraxia Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, EPRX quarterly stockholders equity has changed by -$5.31 M (-35.81%)